SWEDISH ORPHAN BIOVITRUM
🇫🇷France
Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE)
Phase 3
Completed
- Conditions
- CancerLeukemiaLymphoma
- Interventions
- First Posted Date
- 2005-04-25
- Last Posted Date
- 2014-09-15
- Lead Sponsor
- Swedish Orphan Biovitrum
- Target Recruit Count
- 47
- Registration Number
- NCT00109031
Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer
Phase 3
Completed
- Conditions
- Head and Neck CancerSolid TumorsMucositisStomatitisSquamous Cell Carcinoma
- Interventions
- First Posted Date
- 2005-01-13
- Last Posted Date
- 2016-09-27
- Lead Sponsor
- Swedish Orphan Biovitrum
- Target Recruit Count
- 188
- Registration Number
- NCT00101582
Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
Phase 2
Completed
- Conditions
- Non-Small Cell Lung CancerDysphagiaLung Cancer
- Interventions
- First Posted Date
- 2004-10-27
- Last Posted Date
- 2017-03-14
- Lead Sponsor
- Swedish Orphan Biovitrum
- Target Recruit Count
- 100
- Registration Number
- NCT00094861
Pharmacokinetic Study of Palifermin in Subjects Receiving Radiation Therapy and Chemotherapy Followed by Blood Stem Cell Support
Phase 1
Completed
- Conditions
- LymphomaLeukemiaMyeloma
- Interventions
- Radiation: radiotherapyDrug: Chemotherapy
- First Posted Date
- 2003-10-08
- Last Posted Date
- 2014-10-24
- Lead Sponsor
- Swedish Orphan Biovitrum
- Target Recruit Count
- 25
- Registration Number
- NCT00070616
© Copyright 2025. All Rights Reserved by MedPath